APA (7th ed.) Citation

Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., . . . Melenhorst, J. J. (2018). Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nature medicine, 24(5), 563-571. https://doi.org/10.1038/s41591-018-0010-1

Chicago Style (17th ed.) Citation

Fraietta, Joseph A., et al. "Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia." Nature Medicine 24, no. 5 (2018): 563-571. https://doi.org/10.1038/s41591-018-0010-1.

MLA (9th ed.) Citation

Fraietta, Joseph A., et al. "Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia." Nature Medicine, vol. 24, no. 5, 2018, pp. 563-571, https://doi.org/10.1038/s41591-018-0010-1.